Development Level

Tchem 2 | 1,890
Tbio 1 | 10,625

IMPC Phenotype

abnormal retina morphology 1 | 100
limb grasping 1 | 35

Disease

Cancer 3 | 2,346
Arthritis 2 | 248
Breast cancer 2 | 3,098
Diabetic Retinopathy 2 | 53
Heart disease 2 | 279
Kidney disease 2 | 397
Liver Cirrhosis 2 | 101
Oral Submucous Fibrosis 2 | 18
Prenatal Exposure Delayed Effects 2 | 9
Proliferative vitreoretinopathy 2 | 17
Pulmonary Fibrosis 2 | 66
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
cystic fibrosis 2 | 1,670
diabetes mellitus 2 | 1,663
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
lung adenocarcinoma 2 | 2,714
lung cancer 2 | 4,473
malignant mesothelioma 2 | 3,163
nasopharyngeal carcinoma 2 | 1,056
ovarian cancer 2 | 8,491
psoriasis 2 | 6,685
ulcerative colitis 2 | 2,087
Acquired immunodeficiency syndrome 1 | 164
Acrocephalosyndactylia 1 | 15
Adenocarcinoma 1 | 115
Adenoma 1 | 165
Adhesions of uterus 1 | 4
Alzheimer's disease 1 | 644
Ankylosis 1 | 25
Aortic valve insufficiency 1 | 22
Atherosclerosis 1 | 275
Atopic dermatitis 1 | 944
Axonal neuropathy 1 | 17
Brain infarction 1 | 17
Cardiomegaly 1 | 66
Charcot-Marie-Tooth disease 1 | 74
Cleft Lip 1 | 91
Cleft palate 1 | 125
Cocaine-Related Disorders 1 | 88
Congenital diaphragmatic hernia 1 | 44
Contact Dermatitis 1 | 80
Corneal Neovascularization 1 | 2
Craniosynostosis 1 | 47
Decubitus ulcer 1 | 10
Dental fluorosis 1 | 16
Depressive disorder 1 | 48
Diaphragmatic Hernia 1 | 40
Diffuse cutaneous systemic sclerosis 1 | 17
Disease Progression 1 | 125
Down syndrome 1 | 548
Female infertility 1 | 28
Focal glomerulosclerosis 1 | 22
Gastrointestinal system disease 1 | 50
Gestational Diabetes 1 | 17
Glaucoma 1 | 135
Glioma 1 | 66
Gliosis 1 | 16
Heart failure 1 | 80
Hemangioma 1 | 35
Hepatitis B, Chronic 1 | 15
Hypertension 1 | 293
Hypertensive disease 1 | 193
IGA Glomerulonephritis 1 | 454
Inflammation 1 | 109
Keratitis 1 | 42
Kidney Diseases 1 | 86
Liver Cirrhosis, Experimental 1 | 108
Liver disease 1 | 219
Lung Neoplasms 1 | 171
Lung disease 1 | 136
Lung diseases 1 | 48
Mesothelioma 1 | 40
Myocardial Ischemia 1 | 169
Nephrotic Syndrome 1 | 48
Nerve Degeneration 1 | 73
Neurodegenerative disease 1 | 383
Neuropathy 1 | 210
Papillary thyroid carcinoma 1 | 37
Parkinson's disease 1 | 364
Peripheral Neuropathy 1 | 303
Pneumonia 1 | 133
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 | 11
Reperfusion Injury 1 | 84
Retinal Degeneration 1 | 49
Retinal detachment 1 | 33
Seizures 1 | 95
Systemic scleroderma 1 | 66
Thrombocythemia, Essential 1 | 12
Tonic-clonic epilepsy 1 | 47
Toxic encephalopathy 1 | 131
Ureteral disease 1 | 23
Vascular disease 1 | 281
adrenocortical carcinoma 1 | 1,427
breast carcinoma 1 | 1,614
fibroadenoma 1 | 557
hereditary spastic paraplegia 1 | 313
limited scleroderma 1 | 19
pancreatic cancer 1 | 2,300
pituitary cancer 1 | 1,972
spina bifida 1 | 1,064

Tissue

Blood and immune system 3 | 17,994
Cardiovascular System 3 | 17,957
Digestive Tract 3 | 18,472
Endocrine System 3 | 18,511
Female tissues 3 | 18,646
Liver and Pancreas 3 | 18,135
Male tissues 3 | 17,968
Nervous System 3 | 18,560
Respiratory system 3 | 17,483
Skin and soft tissues 3 | 18,114
Urinary Tract 3 | 18,443

Target Family

Non-IDG 3 | 11,969

Grant Application

5R01CA058093-15 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Connective tissue growth factor CTGF Tchem Non-IDG -3.25038 1870.5 497
Fibroblast growth factor 2 FGF2 Tchem Non-IDG -3.99298 10115.4 658
Protein TFG TFG Tbio Non-IDG -2.27385 157.3 175